ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Isothermal nucleic acid amplification technologies have applications in the field of recombinant DNA and molecular biology techniques. These techniques are used in the detection and analysis of small quantity of nucleic acids. Polymerase chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists of thermocycling machine that facilitates separation and amplification of DNA strands. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature. Various isothermal amplification techniques have been developed as alternatives to polymerase chain reaction (PCR).

Isothermal amplification chemistry has also been used to diagnostics with great success and is utilized in several commercial molecular diagnostic platforms, serving large testing centers and point-of-care markets. The advantage of these methods is that the nucleic acids amplification can be carried out at constant temperature, unlike PCR that requires cyclic temperature changes. Moreover, isothermal amplification can be conducted directly in living cells. The thermodynamics process in which the temperature of the whole system remains constant over a period of time is called isothermal process. Thus, the constant temperature of any system makes the process an isothermal process. For example, melting of ice at zero degree is an example of an isothermal process.

Market Dynamics

Increasing adoption of organic growth strategies such as approvals from healthcare regulatory authorities for innovative technologies by key market players, in order to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in September 2020, Abbott, a healthcare  company that helps people live more fully at all stages of life,  received approval from Health Canada for the ID NOW rapid COVID-19 testing device for usage in Canada.  

Key features of the study

• This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (USD 3,701.7 Mn), and compound annual growth rate (CAGR 10.5%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies.
• Key players covered as a part of this study include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics.
• Global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global isothermal nucleic acid amplification technology (INAAT) market.

Market Segmentation

• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type
  • Instruments
  • Reagents and Kits
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application
  • Infectious Disease Diagnostics
  • Blood Screening
  • Others
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology
  • Helicase Dependent Amplification (HAD)
  • Nicking Enzyme Amplification Reaction (NEAR)
  • Nucleic Acid Sequence Based Amplification (NASBA)
  • Transcription Medicated Amplification (TMA)
  • Single Primer Isothermal Amplification (SPIA)
  • Loop-mediated Isothermal Amplification (LAMP)
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others
• Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Company Profiles
  • Alere Inc.
  • Becton, Dickinson & Company
  • BioHelix Corporation
  • BioMerieux Biotechnology Company
  • Hologic Gene-Probe
  • QIAGEN Company
  • Thermo Fisher Scientific Inc.
  • Lucigen Corporation
  • Quidel Corporation
  • NuGEN